The clinical potential of cyclooxygenase-2-specific inhibitors

American Journal of Medicine

Volumn 106, Issue 5 B, 1999, Pages 51S-57S

  Lipsky, Peter E ^a  

^a Division of Rheumatic Diseases UT Southwestern   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; CANCER PREVENTION; COLON CANCER; CONFERENCE PAPER; HUMAN; KIDNEY DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033620679     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00117-5     Document Type: Conference Paper

References (51)

1. Dubois R.N., Abramson S.B., Crofford L., et al. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
2. Harris R.C., McKenna J.A., Jacobson H.R., et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 94:1994;2504-2510.
3. Dubois R.N., Tsujii M., Bishop P., et al. Cloning and characterization of a growth factor inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol. 266:1994;G822-G827.
4. O'Neill G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330:1993;156-160.
5. Smith W.L., Bell T.G. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol. 235:1978;F4512-FF457.
6. Wilcox C.S., Welch W.J., Murad F., et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA. 89:1992;11993-11997.
7. Mundel P., Bachmann S., Bader M., et al. Expression of nitric oxide synthase in the kidney macula densa cells. Kidney Int. 42:1992;1017-1019.
8. Salvemini D., Misko T.P., Masferrer J.L., et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1993;7240-7244.
9. Salvemini D., Seibert K., Masferrer J.L., et al. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 93:1994;1940-1947.
10. Guan Y., Chang M., Cho W., et al. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol. 273:1997;F18-F26.
11. Hartner A., Goppelt-Struebe M., Hilgers K.F. Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension. 31:(part 2):1998;201-205.
12. Lorenz J.N., Greenberg S.G., Briggs J.P. The macula densa mechanism for control of renin secretion. Semin Nephrol. 13:1993;531-542.
13. 2. Prostaglandins. 14:1977;1095-1104.
14. Francisco L.J., Osborn J.L., DiBona G.F. Prostaglandins in renin release during sodium deprivation. Am J Physiol. 243:1982;F537-F542.
15. Linas S.L. Role of prostaglandins in renin secretion in the isolated kidney. Am J Physiol. 246:1984;F811-F818.
16. Ito S., Carretero O.A., Abe K., et al. Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int. 35:1989;1138-1144.
17. Greenberg S.G., Lorenz J.N., He X.-R., et al. Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion. Am J Physiol. 165:1993;F578-F583.
18. Zhang M.-Z., Wang J.-L., Cheng H.-F., et al. Cyclooxygenase-2 in rat nephron development. Am J Physiol. 273:1997;F994-F1002.
19. Morham S.G., Langenbach R., Loftin C.D., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
20. Seibert K., Masferrer J.L., Needleman Salvemini D. Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney. Br J Pharmacol. 117:1996;1016-1020.
21. Komhoff M., Grone H.J., Klein T., et al. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney implication for renal function . Am J Physiol. 272:1997;F460-F468.
22. Yamagata K., Andreasson K.I., Kaufmann W.E., et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons regulation by synaptic activity and glucocorticoids . Neuron. 1192:1993;371-386.
23. Tocco G., Freire-Moar J., Schreiber S.S., et al. Maturational regulation and regional induction of cylooxygenase-2 in rat brain implications for Alzheimer's disease . Exp Neurol. 144:1997;339-349.
24. Kaufmann W.E., Worley P.F., Pegg J., et al. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA. 93:1996;2317-2321.
25. Bauer M.K.A., Lieb K., Schulze-Osthoff K., et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem. 243:1997;726-731.
26. Rich J.B., Rasmusson D.X., Folstein M.F., et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 45:1995;51-55.
27. Rogers J., Kirby L.C., Hempelman S.R., et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
28. Breitner J.C.S., Welsh K.A., Robinette C.D., et al. Alzheimer's disease in the NAS-NRC Registry of Aging twin veterans. II. Longitudinal findings in a pilot series. Dementia. 5:1994;99-105.
29. Breitner J.C.S., Gau B.A., Welsh K.A., et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease initial results of a co-twin control study . Neurology. 44:1994;227-232.
30. Stewart W.F., Kawas C., Corrada M., Metter J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 48:1997;626-632.
31. Giannella R.A., Formal S.B., Damrain G.J., Collins H. Pathogenesis of salmonellosis studies of fluid secretion, mucosal invasion, and morphologic reactions in the rabbit ileum . J Clin Invest. 52:1973;441-458.
32. 2alpha production. J Clin Invest. 100:1997;296-309.
33. Reuter B.K., Asfaha S., Buret A., et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest. 98:1996;2076-2085.
34. Jacoby R.F., Marshall D.J., Newton M.A., et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56:1996;710-714.
35. Chulada P.C., Doyle C., Gaul B., et al. Cyclooxygenase-1 and -2 deficiency decrease spontaneous intestinal adenomas in the Min mouse. Proc Am Assoc Cancer Res. 39:1998;195.
36. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
37. DuBois R.N., Radhika A., Reddy B.S., Entingh A.J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1996;1259-1262.
38. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:1997;3336-3340.
39. Nakatsugi S., Fukutake M., Takahashi M., et al. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in min mice. Jpn J Cancer Res. 88:1997;1117-1120.
40. Takahashi M., Fukutake M., Yokota S., et al. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J Cancer Res Clin Oncol. 122:1996;219-222.
41. Yoshimi N., Kawabata K., Hara A., et al. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Jpn J Cancer Res. 88:1997;1044-1051.
42. Reddy B.S., Rao C.V., Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:1996;4566-4569.
43. Kawamori T., Rao C.V., Seibert K., Reddy B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58:1998;409-412.
44. Reddy B.S., Rao C.V., Rivenson A., Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis. 1498:1993;1493-1497.
45. Eberhart C.E., Coffey R.J., Radhika A., et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
46. Sano H., Kawahito Y., Wilder R.L., et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
47. Kargman S.L., O Neill G.P., Vickers P.J., et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
48. Kune G.A., Kune S., Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications case control results from the Melbourne Colorectal Cancer Study . Cancer Res. 48:1988;4399-4404.
49. Thun M.J., Namboodri M.M., Heath C.W. Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 325:1991;1593-1596.
50. Lim H., Paria B.C., Das S.K., et al. Multiple female reproductive failures in cyclooxygenase 2 deficient mice. Cell. 91:1997;197-208.
51. Chakraborty I., Das S.K., Wang J., Dey S.K. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol. 16:1996;107-122.